Partners & Sponsors
The RUNX1 Research Program has partnered with two distinguished cancer research foundations to extend our organization’s reach and potential.
We have partnered with the renowned childhood cancer foundation Alex’s Lemonade Stand Foundation (ALSF) to accelerate research on RUNX1-FPD by providing a 2-year grant program totaling $250,000 for each recipient research team.
Along with the Leukemia & Lymphoma Society (LLS), we co-sponsor a competitive grant program which funds $200,000 per year for 3 years to awardees.
Scientific Advisory Board
Our Scientific Advisory Board is a working body of researchers esteemed in their respective fields, fulfilling an important scientific advisory role for the RUNX1 Research Program. The team offers scientific advice, suggests the direction of our research, helps to review grant applications and fosters collaborative relationships within the scientific community. We are indebted to their expertise, and for their insight and assistance.
Nancy A. Speck, Ph.D.
Nancy is the Chairperson and Scientific Director, RUNX1 Research Program. Dr. Speck chairs the Department of Cell and Developmental Biology in the Perelman School of Medicine at the University of Pennsylvania.
Paul Liu, M.D., Ph.D.
Dr. Liu is the Deputy Scientific Director of the National Human Genome Research Institute. He received his M.D. and residency training in internal medicine in Beijing, China.
Gary Gilliland, M.D., Ph.D.
Dr. Gilliland is President and Director of the Fred Hutchinson Cancer Research Center. He received his Ph.D. in Microbiology from UCLA and his M.D. from the University of California, San Francisco.
Benjamin Ebert, MD, PhD
Dr. Ebert is a Professor of Medicine at Harvard Medical School, an Institute Member of the Broad Institute, and Leader of the Leukemia Program for the Dana-Farber/Harvard Cancer Center.
We at the RRP are committed to finding a pre-leukemic cure for the inherited blood disorder RUNX1-FPD.
We promote awareness, connect stakeholders, fund and support targeted and innovative research, and advocate for patients in the RUNX1 community.
The RRP Team
Monica and Tim Babich co-founded RRP in late 2015 and are Co-Directors still today. Dr. Katrin Ericson joined the organization as Executive Director in October 2018. Amanda Eggen (updated team picture to come!) is our new Patient Engagement and Clinical Program Manager.
Dr. Ericson brings to the RRP a diverse set of experiences that span multiple sectors of the scientific and medical landscape. Most recently, she was at Amgen working in the Medical Affairs department for close to 8 years.